Using the nanoHeart Assay (TM) and patented representative human stem cell-derived cardiac tissue models, NanoSurface screens libraries of drugs for cardiotoxicity as a service. NanoSurface also sells products that enable researchers to culture mature and structured tissue models for disease modeling, tissue engineering, and drug development/discovery.